Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1468)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (54)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (55)
¹ÙÀÌ¿ÀÀåºñ (323)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (53)
À¯ÀüÀÚ Ä¡·á/RNAi (100)
Àç»ýÀÇÇÐ (125)
Ç×ü/¸é¿ª (187)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

À¯ÀüÀÚ Ä¡·á/RNAi ½ÃÀåÁ¶»çº¸°í¼­

À¯ÀüÀÚ Ä¡·á/RNAi ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.


»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 100 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Gene Therapy - technologies, markets and companies
»óǰÄÚµå :70931
À¯ÀüÀÚ Ä¡·á ±â¼ú ¹× °¢Á¾ Áúȯ ŸÀÔº° À¯ÀüÀÚ Ä¡·á µ¿Çâ, °ü·Ã ±â¾÷ÀÇ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,000
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
RNAi - technologies, markets and companies
»óǰÄÚµå :70930
RNAi¿Í ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå, ¾ÐŸ¸Ó, ¸®º¸ÀÚÀÓ, ÆéŸÀ̵åÇÙ»ê ¹× LNAÀ» ÀÌ¿ëÇÑ ±âŸ ¾ÈƼ¼¾½º ¾îÇÁ·ÎÄ¡¸¦ ºñ±³ ºÐ¼®Çϰí, °¢Á¾ RNAi ±â¼úÀÇ ÇØ¼³ ¹× °ü·Ã ±â¾÷ÀÇ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,000
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :228447
ÇÙ»ê ÀǾàǰ(Nucleic Acid Drugs) ºÎ¹®ÀÇ ¿¬±¸°³¹ß Ãֽе¿ÇâÀ» ºÐ¼®Çϰí, ÁÖ¿ä 3°³ ºÎ¹®(¾ÐŸ¸Ó Ä¡·áÁ¦, ¾ÈƼ¼¾½º Ä¡·áÁ¦, RNA °£¼·)ÀÇ ¿¬±¸°³¹ß Æ÷Æ®Æú¸®¿À °³¿ä, ¾÷°è³» ¿¬±¸°³¹ß°ú »ç¾÷ Á¦ÈÞ Ãֽе¿Çâ, °èÃþºÐ¼®¹ý(AHP)¿¡ ±Ù°ÅÇÑ ¿¬±¸°³¹ß Æ÷Æ®Æú¸®¿À(±¸¼º ¿É¼Ç) Æò°¡ µîÀÇ Á¶»ç °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý ¹®ÀÇ
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Technical Insights, Inc.
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :226592
¼¼°è °¢±¹ÀÇ miRNA(¸¶ÀÌÅ©·Î RNA, ¸®º¸ÇÙ»ê) ¿¬±¸ °ü·Ã ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ÃֽŠ¿¬±¸°³¹ß µ¿Çâ°ú ±â´ëµÇ´Â ÀÌ¿ë ºÐ¾ß, ÁÖ¿ä±¹ÀÇ °³¹ß µ¿Çâ, ÁÖ¿ä ±â¾÷ °³¿ä¿Í Ȱµ¿ µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 60 Pages
Epigenetic Therapies and Technologies: World Market Prospects 2011-2021
»ùÇÃ
»óǰÄÚµå :224392
¼¼°èÀÇ ¿¡ÇÇÁ¦³×ƽ½º Ä¡·á(Epigenetic Therapies) ¹× °ü·Ã ±â¼ú ½ÃÀå¿¡ ´ëÇØ Á¶»çÇϰí, 2021³â±îÁöÀÇ ¼¼°è, Áö¿ªº°, ÇÏÀ§½ÃÀ庰(¿¡ÇÇÁ¦³×ƽ½º Ä¡·á, ¿¡ÇÇÁ¦³×ƽ½º Áø´Ü, ¿¡ÇÇÁ¦³×ƽ½º ±â¼ú) ½ÃÀå ¿¹Ãø, ½ÃÀåÀÇ SWOT ºÐ¼®, »õ·Î¿î »ç¾÷ ±âȸ, ÁÖ¿ä ±â¾÷ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,642
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 148 Pages
MicroRNA Market Trends 2011
»ùÇÃ
»óǰÄÚµå :219016
MicroRNA ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå µ¿Çâ°ú Á¦Ç°º° º¥´õ µ¿Çâ, MicroRNA ¿¬±¸ ''ÇÖ½ºÆÌ''°ú ¿¬±¸ Å׸¶ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,720
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Select Biosciences, Ltd.
ÆäÀÌÁö¼ö  
Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :210423
°Ô³ë¹Í½º(Genomics), ÇÁ·ÎÅ׿À¹Í½º(Proteomics) ¹× ¿¡ÇǰԳë¹Í½º(Epigenomics)ÀÇ ½Ã·á Á¶Á¦(Sample Preparation) Á¦Ç°, ±â¼ú, ¼­ºñ½º ³»¿ëÀ» Á¶»ç ºÐ¼®Çϰí, ¼¼°è ½ÃÀåÀÇ 2009-2010³â ½ÇÀû°ú 2016³â±îÁö ¿¹Ãø, ÃÖ±ÙÀÇ Æ¯Çã µ¿Çâ, ½ÃÀå ÁøÃâ ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,850
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 146 Pages
»ùÇÃ
»óǰÄÚµå :210366
¼¼°èÀÇ ºÐÀÚ¼¼Æ÷À¯ÀüÇÐ(Molecular Cytogenetics) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ºÐÀÚ¼¼Æ÷À¯ÀüÇÐ ¹× FISH ±â¼ú °³¿ä, Á¦Ç° Ãâ½Ã µ¿Çâ, ¼¼°èÀÇ ÁÖ¿ä Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,800
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 239
French Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208075
ÇÁ¶û½ºÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
US Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208074
¹Ì±¹ÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 8,400
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
UK Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208073
¿µ±¹ÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Spanish Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208072
½ºÆäÀÎÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Japanese Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208071
ÀϺ»ÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 7,500
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Italian Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208070
ÀÌÅ»¸®¾ÆÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
German Nucleic Acid Testing Market
»ùÇÃ
»óǰÄÚµå :208069
µ¶ÀÏÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦, ±â¼ú µ¿Çâ, ÇâÈÄ 10³â°£ ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Nucleic Acid Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
»ùÇÃ
»óǰÄÚµå :208068
¼¼°èÀÇ ÇÙ»ê ½ÃÇè ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±¸Á¶ ¹× ±Ô¸ð, ¼ºÀå Àü¸Á°ú ±¹°¡º° ½ÃÇè¼Ò, ½ÃÇè°Ç¼ö ¿¹Ãø µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Cancer Nucleic Acid Testing
»ùÇÃ
»óǰÄÚµå :208063
¾Ï ÇÙ»ê ½ÃÇè ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÁÖ¿ä ¾ÏÀÇ Á¾·ù¿Í ¾ÏÀ¯ÀüÀÚ °³¿ä¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,450
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Infectious Disease Nucleic Acid Testing
»ùÇÃ
»óǰÄÚµå :208062
°¨¿°Áõ ÇÙ»ê °Ë»ç(Infectious Disease Nucleic Acid Testing) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í °¨¿°Áõ °³¿ä, Ç×»ý ¹°Áú °¨¼ö¼º ¿¡ ´ëÇØ Á¤¸®ÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Gene Therapy Market Analysis
»ùÇÃ
»óǰÄÚµå :207167
¼¼°è °¢±¹ÀÇ À¯ÀüÀÚ Ä¡·á(Gene Therapy) ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ÃֽŠ»ê¾÷ ¹× ½ÃÀå µ¿Çâ, ÁÖ¿ä Ä¡·á ºÐ¾ß, ÁÖ¿ä ±¹°¡, ÁÖ¿ä ¾àÁ¦º° ½ÃÀå ½ÇÀû°ú ¿¹Ãø, ÇöÀçÀÇ ¿¬±¸ °³¹ß »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,200
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 105 Pages
Advances in Omics Technologies
»ùÇÃ
»óǰÄÚµå :209184
¿À¹Í½º(Omics) ºÐ¾ßÀÇ ÁÖ¿ä ÄÄÆ÷³ÍÆ® ±â¼ú µ¿Çâ¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ¿¬±¸ °³¹ß Æ÷Æ®Æú¸®¿À °ü¸®¿¡ ´ëÇÑ Á¦¾È, ¿¬±¸ÀÇ ¹æÇ⼺, ¿¬±¸ °³¹ß ȯ°æ °ü·Ã °úÁ¦, ½ÃÀå ¿ä±¸, ÇâÈÄ µ¿Ç⠵ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý ¹®ÀÇ
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Technical Insights, Inc.
ÆäÀÌÁö¼ö  
Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
»ùÇÃ
»óǰÄÚµå :200908
¼¼°è 7´ë ½ÃÀå¿¡¼­ÀÇ ÇÙ»ê °Ë»ç(Nucleic Acid Testing)ÀÇ µ¿Çâ ¹× ±â¼ú µ¿Çâ, ÇâÈÄ 5³â°£ ¹× 10³â°£ÀÇ °Ë»ç °Ç¼ö¿Í ¸ÅÃâ ¿¹Ãø, ÁÖ¿ä °æÀï ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ¹× ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 28,500
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö 1050 Pages
Global RNAi Market Analysis
»ùÇÃ
»óǰÄÚµå :201214
¼¼°è RNAi(RNA Interference, RNA °£¼·) ½ÃÀåÀÇ ±¤¹üÀ§ÇÑ Á¤º¸¿Í ÇÕ¸®ÀûÀÎ ºÐ¼®À» Á¦°øÇϰí, ½ÃÀå ÀÀ¿ë, ¾÷°è ¹ßÀü, °æÀï ±¸µµ µîÀÇ ºÐ¼®, ½ÃÀå¿¡¼­ ÀÔ¼ö°¡´ÉÇÑ ´Ù¾çÇÑ ºÎ¹®º° Á¦Ç°ÀÇ ºÐ¼®, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù
... ´õº¸±â
°¡°Ý US $ 1,200
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 65 Pages
Life Science Tools and Reagents: Global Markets
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :180726
»ý¸í°úÇÐ Åø ¹× ½Ã¾à ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ÀüüÀÇ °³¿ä ¹× ¾÷°è µ¿Çâ, °Ô³ë¹Í½º, ÇÁ·ÎÅ׿À¹Í½º µîÀÇ ºÎ¹®º° µ¿Çâ, Âü°¡±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,850
¹ßÇàÀÏ 2011³â 04¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 154 Pages
»ùÇÃ
»óǰÄÚµå :201775
¼¼°èÀÇ RNA °£¼·(RNAi : RNA interference) ½ÃÀåÀ» Á¶»çÇϰí, ¾÷°è °³¿ä, RNAiÀÇ Á¦Ç° °³¿ä, Á¦Ç° °³¹ß°ú ÀÓ»ó½ÃÇè, ¹ý±ÔÁ¦ µ¿Çâ, ½ÃÀå ÁøÃâ ±â¾÷ÀÇ °³¿ä, ¼¼°è °¢±¹ÀÇ Áö¿ªº° µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,800
¹ßÇàÀÏ 2011³â 04¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 802
RNAi for Therapeutic Applications: Market Prospects 2011-2021
»ùÇÃ
»óǰÄÚµå :191129
RNA °£¼·(RNAi)ÀÇ Ä¡·á ÀûÀÀ¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °ü·Ã Á¦Ç° ¹× Á¦Á¶ ±â¾÷ µ¿Çâ, 2011¡­2021³â Àü¸Á¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,331
¹ßÇàÀÏ 2011³â 03¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 152 Pages